Supplementary Online Content

Similar documents
Pharmacy Technician Course

Supplementary Online Content

Condition/Procedure Measure Compliance Criteria Reference Attribution Method

Supplementary Online Content

Supplementary Online Content

Supplementary Online Content

Heart Failure (HF) Treatment

Drugs Categories. 4. Which suffix do erectile dysfunction generic drug names often end with?

Supplementary Online Content

Supplementary Online Content

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD

Section 3, Lecture 2

28-Aug-15. RACGP guidelines 2014/15. ADS guidelines Part 1 T2D Guidelines. Part 2 What comes after metformin?

Essentials for Medication Safety

hypertension Head of prevention and control of CVD disease office Ministry of heath

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone

Supplementary Online Content

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.

Coordinators of the Summer School. President of the Hellenic Atherosclerosis Society

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

Supplementary Online Content

Alabama Medicaid Pharmacy Override

Heart Failure Treatments

Neuro Basics SLO Practice (online) Page 1 of 5

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment

Chapter 2 ~ Cardiovascular system

Supplementary Online Content

Quick Guide MEDICATIONS 7th Edition Evan Sisson, Pharm.D., MHA, CDE

Drug Classification and Pharmacologic Actions

Anti-Depressant Medications

Supplementary Online Content

Beta 1 Beta blockers A - Propranolol,

STOPP START Toolkit Supporting Medication Review in the Older Person

Kentucky Department for Medicaid Services. Drug Review Options

Management of Hypertension

Supplementary Online Content

Plan Change Alert. New Market Priced Drug (MPD) Program Effective 11/1/2016. Alaska United Food and Commercial Workers Trust

ASSESSING THE VALUE OF BIOPHARMACEUTICAL INNOVATION IN KEY THERAPY AREAS IN MIDDLE-INCOME COUNTRIES

Index. Note: Page numbers of article titles are in boldface type.

Chapter 5: Health Screening. ACE Personal Trainer Manual Third Edition

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

Supplementary Online Content

Pharmacology 260 Online Course Schedule Summer 2015

Supplementary Online Content

Manual of Clinical Psychopharmacology

Pharmacy Benefit Management

Phosphorus. Diagnostics

Supplementary Online Content

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University

Definition of Congestive Heart Failure

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

I have no disclosures. Disclosures

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents

Supplementary Online Content

ALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic

About the PCTB Examination Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p.

DICOM Correction Item

Back to Basics: The Basics of Medication Monitoring

Blood pressure and pulse should be recorded on a centile chart at each dose adjustment and then at least every 6 months

Definitions of chronic conditions used to define the number of serious comorbidities in the study.

Pre-ALLHAT Drug Use. Diuretics. ß-Blockers. ACE Inhibitors. CCBs. Year. % of Treated Patients on Medication. CCBs. Beta Blockers.

Cardiovascular System

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

By Prof. Khaled El-Rabat

Supplementary Appendix

Patient-Centered Primary Care Scorecard Measures

Hypertension (JNC-8)

Long-Term Care Updates

Diabetes update - Diagnosis and Treatment

Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension

Adult Diabetes Clinician Guide NOVEMBER 2017

Jefferson In the News!

Supplementary Online Content

Supplementary Online Content

Medicinal Chemistry I Examination December 7, 2007 Name Med. Chem. # THERE ARE TWELVE PAGES IN THIS EXAM!

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)

Beta-blockers: Now what? Annemarie Thompson, MD Assistant Professor of Anesthesia and Medicine Vanderbilt University Medical Center

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias

Cardiovascular drugs

STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK. COURSE OUTLINE NURS 204 Pharmacology IV. Prepared By: John Conklin

Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

Prof dr Aleksandar Raskovic DIRECT VASODILATORS

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy

Index. Note: Page numbers of article titles are in boldface type.

How would you manage Ms. Gold

Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on an annual basis.

Checklist for Treating Heart Failure. Alan M. Kaneshige MD, FACC, FASE Oklahoma Heart Institute

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Pharmacology of the Sympathetic Nervous System II

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015

Drugs Used in Heart Failure. Assistant Prof. Dr. Najlaa Saadi PhD pharmacology Faculty of Pharmacy University of Philadelphia

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych

< N=248 N=296

PATIENT-IMPACT SCORECARD

Best Practices in Cardiac Care: Getting with the Guidelines

Session ID: 1001 June 14, 2012

It s Not Just Serotonin: Neurosignaling in Mental Illness

Transcription:

Supplementary Online Content Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Int Med. Published online February 27, 2017. doi:10.1001/jamainternmed.2016.9627 efigure 1. Three Low-Cost Reminder Devices efigure 2. Trial Timeline etable 1. Oral Maintenance Medications etable 2. Odds Ratio of Optimal Adherence by Study Arm, Adjusted for Correlation Within Employer Using Generalized Estimating Equation Results etable 3. Percent Difference in Mean MPR by Study Arm This supplementary material has been provided by the authors to give readers additional information about their work. 2017 American Medical Association. All rights reserved. 1

efigure 1. Three Low-Cost Reminder Devices Pill bottle strip with toggles (Panel A); Pill bottle cap with digital timer (Panel B); Standard pillbox (Panel C) A B C 2017 American Medical Association. All rights reserved. 2

efigure 2. Trial timeline 2017 American Medical Association. All rights reserved. 3

etable 1. Oral maintenance medications Maintenance medication for the treatment of chronic disease Cardiovascular High cholesterol Coronary artery disease Diabetes Heart failure Hypertension Non cardiovascular Breast cancer Benign prostatic hypertrophy Schizophrenia, bipolar disorder, anxiety Arrhythmia Medication classes Statin and statin combinations Bile acid sequestrants Fibrates Nicotinic acid derivatives Isosorbide Ranolazine Platelet inhibitors Amylin analogs GLP 1 receptor agonists Sulfonylureas Biguanides Meglitinide analogs Alpha glucosidase inhibitors DPP 4 inhibitors Thiazoledinediones Cardiac glycoside Selective aldosterone receptor agonists Nitrate and vasodilator combinations Spironolactone Diuretics Angiotensin converting enzyme inhibitors Angiotensin II receptor blockers Direct renin inhibitors Anti adrenergic antihypertensives Beta blockers Diuretics Calcium channel blockers Tamoxifen Aromatase inhibitors Toremifene Alpha blockers Finasteride Combination BPH agents Antipsychotics atypical Antianxiety medications Antiarrhythmics 2017 American Medical Association. All rights reserved. 4

Parkinson s disease Seizure or epilepsy Additional maintenance medication condition Depression Carbidopa Levodopa combination COMT inhibitors Monoamine oxidase inhibitors Carbidopa Anticonvulsants Medication classes Alpha 2 receptor antagonists Monoamine oxidase inhibitors Modified cyclics Tricyclic agents Selective serotonin reuptake inhibitors Serotonin and norepinephrine reuptake inhibitors Thienbenzodiazepine and SSRI combination 2017 American Medical Association. All rights reserved. 5

etable 2. Odds ratio of optimal adherence by study arm, adjusted for correlation within employer using generalized estimating equation results Outcome Versus control Head to head Pillbox Digital timer cap Pill bottle strip Pillbox vs. Digital timer cap Pillbox vs. Pill bottle strip Digital timer cap vs. Pill bottle strip Primary All CVD and nondepression 1.04 (0.95, 1.14) 1.00 (0.87, 1.16) 0.94 (0.88, 1.00) 1.00 (0.93, 1.14) 1.10 (0.98, 1.24) 1.05 (0.96, 1.15) maintenance medications (Chronic Disease stratum) Secondary 1 All CVD 1.03 (0.94, 1.13) 1.01 (0.88, 1.16) 0.95 (0.89, 1.02) 1.02 (0.91, 1.14) 1.08 (0.95, 1.24) 1.04 (0.96, 1.13) medications Secondary 2 Antidepressants (Antidepressant stratum) 1.02 (0.87, 1.19) 0.96 (0.82, 1.13) 0.93 (0.78, 1.11) 1.06 (0.96, 1.17) 1.13 (1.06, 1.22) 1.03 (0.92, 1.16) 2017 American Medical Association. All rights reserved. 6

etable 3. Percent difference in mean MPR by study arm Outcome Primary All CVD and nondepression maintenance medications Secondary 1 All CVD medications Secondary 2 Antidepressants *Absolute change in MPR x100 Versus control Pillbox Digital timer cap Pill bottle strip Pillbox vs. Digital timer cap Head to head Pillbox vs. Pill bottle strip Digital timer cap vs. Pill bottle strip 0.49 ( 0.52, 1.50) 0.24 ( 0.77, 1.24) 0.62 ( 1.32, 1.10) 0.25 ( 0.57, 1.08) 0.47 ( 0.69, 1.62) 0.44 ( 0.71, 1.59) 0.24 ( 0.87, 1.34) 0.37 ( 0.73, 1.47) 0.07 ( 1.22, 1.35) 0.14 ( 1.04, 0.77) 0.20 ( 1.00, 1.41) 0.22 ( 0.98, 1.42) 0.13 ( 1.70, 1.43) 0.79 ( 2.36, 0.78) 1.14 ( 3.00, 0.73) 0.66 ( 0.62, 1.93) 0.86 ( 0.91, 2.64) 0.59 ( 1.18, 2.35) 2017 American Medical Association. All rights reserved. 7